physiolog
cholesterol
metabol
impli
gener
seri
oxid
deriv
whose
oxysterol
far
investig
one
potenti
multifacet
involv
human
pathophysiolog
regard
noteworthi
broad
antivir
activ
display
defin
side
chain
oxysterol
particular
although
antivir
mechan
may
vari
depend
virushost
interact
oxysterol
share
common
featur
hamper
viral
replic
interact
cellular
protein
report
first
analysi
modul
cell
proteom
two
oxysterol
besid
yield
addit
clue
potenti
involv
regul
sterol
metabol
provid
novelinsight
mechan
underli
inhibit
viru
entri
traffick
within
infect
cell
show
downregul
junction
adhes
moleculea
jama
cation
independ
isoform
receptor
mprci
two
crucial
molecul
replic
virus
exploit
adhes
molecul
endosom
pathway
enter
diffus
within
target
cell
last
year
solid
evid
provid
remark
antivir
effect
defin
oxysterol
essenti
enzymat
origin
cholesterol
deriv
molecul
prove
effect
inhibit
replic
wide
span
viral
pathogen
characteris
highli
diverg
replic
strategi
structur
featur
relat
studi
member
famili
certainli
physiolog
oxysterol
whose
product
enzym
hydroxylas
proven
interferoninduc
moreov
similarli
strong
inhibit
replic
envelop
nonenvelop
virus
demonstr
exert
well
product
ubiquit
mitochondri
enzym
hydroxylas
far
repres
oxysterol
human
plasma
unpreced
antivir
spectrum
reli
least
part
abil
oxysterol
modifi
composit
cellular
subcellular
membran
viral
pathogen
cross
order
enter
host
cell
hijack
replic
machineri
oxysterolinduc
modif
trigger
differ
mechan
direct
interact
oxysterol
cellular
membran
b
interact
cellular
protein
involv
cholesterol
shuttl
intracellular
membran
oxysterolbind
protein
osbp
c
modul
express
enzym
involv
cholesterol
metabol
bind
specif
nuclear
receptor
liver
x
receptor
lxr
estrogen
receptor
er
cell
viral
attack
instanc
redoxdepend
upregul
nfkbdriven
overproduct
proinflammatori
cytokin
particular
aim
investig
mechan
behind
import
properti
side
chain
oxysterol
deem
use
afford
analysi
possibl
modul
cell
proteom
date
two
report
investig
effect
enzymat
vascular
cell
proteom
data
far
access
far
sidechain
enzymat
oxysterol
concern
mous
monoclon
antibodi
direct
jama
purchas
santa
cruz
biotechnolog
inc
dalla
tx
usa
mous
monoclon
antibodi
direct
actin
purchas
millipor
secondari
antibodi
antimous
igg
horseradish
hrp
link
purchas
ge
healthcar
uk
chalfont
st
gile
uk
sigma
dissolv
steril
ethanol
mm
human
epitheli
adenocarcinoma
hela
cell
african
green
monkey
kidney
epitheli
cell
propag
dulbecco
modifi
eagl
medium
dmem
gibcobrl
gaithersburg
md
supplement
heatinactiv
fetal
bovin
serum
fb
gibcobrl
penicillinstreptomycin
solut
euroclon
atmospher
co
hela
cell
silaclabel
use
silac
dmem
thermoscientif
defici
lysin
arginin
supplement
dialyz
fetal
bovin
serum
invitrogen
medium
appropri
amino
acid
ad
follow
unlabel
llysin
larginin
sigma
use
obtain
lightlabel
cell
c
n
larginin
cambridg
isotop
laboratori
c
n
llysin
cambridg
isotop
laboratori
use
obtain
heavylabel
cell
final
amino
acid
concentr
correspond
standard
dmem
composit
mgl
arginin
mgl
lysin
cell
cultur
least
seven
replic
achiev
complet
label
full
protein
label
verifi
gelcm
analysi
data
shown
exponenti
grow
hela
cell
either
unlabel
silaclabel
seed
cm
dish
h
cell
treat
h
silac
dmem
supplement
dializ
fb
control
sampl
prepar
treat
cell
cultur
medium
supplement
equal
volum
ethanol
correspond
vv
cell
media
oxysterol
direct
revers
protocol
perform
accord
follow
scheme
direct
experi
unlabel
hela
cell
chosen
untreat
control
label
hela
cell
oxysteroltr
revers
experi
unlabel
hela
oxysteroltr
label
hela
chosen
untreat
control
h
treatment
cell
wash
twice
phosphat
buffer
salin
contain
ethylenediaminetetraacet
acid
pbsedta
trypsin
wash
pb
count
heavylabel
lightunlabel
hela
cell
mix
proport
million
form
direct
revers
silac
sampl
ie
four
sampl
direct
revers
direct
revers
mix
cell
pellet
solubil
laemmli
sampl
buffer
biorad
dithiothreitol
mm
extract
protein
protein
extract
centrifug
pellet
cellular
debri
min
g
clarifi
protein
extract
load
sodium
dodecyl
sulphat
sd
polyacrylamid
gel
kd
mini
protean
tgx
biorad
protein
electrophoresi
v
min
gel
stain
coomassi
blue
biosaf
biorad
lane
correspond
one
silac
sampl
cut
subsequ
band
differ
molecular
weight
order
obtain
rough
fraction
sampl
gel
slice
reduc
mm
dithiothreitol
sigma
mm
ammonium
bicarbon
sigma
min
alkyl
cystein
residu
incub
mm
iodoacetamid
sigma
mm
ammonium
bicarbon
min
rt
dark
protein
ingel
digest
overnight
use
trypsin
sequenc
grade
roch
solubil
mm
ammonium
bicarbon
gel
slice
peptid
extract
gel
firstli
formic
acid
acetonitril
two
extract
gel
slice
pool
elut
peptid
dri
vacuum
concentr
martin
christ
solubil
formic
acid
five
peptid
solubil
formic
acid
load
nano
column
picofrit
halo
id
new
object
rslcnano
system
ultim
dionex
control
softwar
chromeleon
xpress
dionex
version
peptid
separ
use
min
linear
gradient
acetonitril
formic
acid
acetonitril
formic
acid
onlin
electrospray
ltq
orbitrap
xl
mass
spectromet
equip
nanospray
ion
sourc
thermo
mass
spectromet
oper
data
depend
acquisit
dda
mode
control
softwar
xcalibur
version
thermo
acquir
full
ms
spectra
mz
rang
resolut
fwhm
mz
msm
spectra
obtain
collis
induc
dissoci
cid
abund
multicharg
ion
automat
gain
control
aug
set
acquisit
full
ms
spectra
msm
spectra
avoid
redund
two
subsequ
occurr
less
precursor
ion
alreadi
select
fragment
dynam
exclud
softwar
maxquant
version
use
extract
peak
spectra
match
human
protein
databas
download
decemb
uniprot
entri
mass
valu
recalibr
use
first
search
option
follow
main
search
perform
use
follow
paramet
enzym
trypsin
maximum
number
miss
cleavag
ms
mass
toler
ppm
msm
mass
toler
da
variabl
modif
oxid
met
fix
modif
carbamidomethyl
cy
spectra
collect
fraction
silac
sampl
analys
simultan
specifi
correct
experiment
design
direct
revers
assay
requantifi
match
run
option
select
decoy
mode
base
revers
databas
activ
peptid
fals
discoveri
rate
fdr
set
protein
fdr
set
four
silac
sampl
name
direct
revers
direct
revers
analys
simultan
increas
number
protein
identif
quantif
sampl
analys
separ
consid
revers
direct
assay
independ
replic
analys
rigor
qualiti
filter
use
filter
raw
protein
list
obtain
maxquant
protein
identifi
two
peptid
least
uniqu
peptid
replic
consid
genuin
identif
analys
protein
quantifi
least
two
peptid
replic
analys
replic
distribut
protein
ratio
use
detect
protein
upand
downregul
oxysterol
use
threshold
percentil
ratio
distribut
protein
heavylight
hl
ratio
percentil
direct
assay
percentil
revers
assay
consid
upregul
oxysterol
protein
hl
ratio
percentil
direct
assay
percentil
revers
assay
consid
downregul
oxysterol
normal
silac
ratio
valu
provid
maxquant
use
protein
quantif
instead
raw
ratio
order
elimin
experiment
bia
due
variat
overal
content
heavi
light
protein
sampl
list
protein
modul
oxysterol
analys
use
string
version
detect
interact
perform
enrich
analysi
gene
ontholog
go
categori
kegg
pathway
consid
enrich
probabl
find
observ
number
protein
order
valid
result
silac
proteom
analysi
immunoblot
perform
briefli
hela
cell
cell
plate
well
plate
treat
reach
confluenc
control
sampl
prepar
treat
cell
cultur
medium
supplement
equal
volum
ethanol
correspond
vv
cell
media
h
cell
wash
twice
steril
pb
harvest
lyse
denatur
condit
extract
protein
denatur
boil
min
separ
sd
polyacrylamid
gel
electrophoresi
page
transfer
polyvinyliden
difluorid
pvdf
membran
membran
block
overnight
pb
tween
milk
powder
membran
incub
primari
antibodi
h
wash
time
pb
tween
milk
powder
incub
h
secondari
antibodi
coupl
horseradish
peroxidas
wash
extens
prior
develop
enhanc
chemiluminesc
method
band
densiti
compar
use
imagej
softwar
intens
actin
band
use
normal
valu
possibl
result
express
percentag
compar
treat
cell
cell
incub
cultur
medium
alon
statist
signific
differ
p
assess
oneway
analysi
varianc
oneway
anova
hela
cell
challeng
h
presenc
absenc
final
concentr
oxysterol
dose
incub
time
previous
show
fulli
abolish
rhinoviru
rotaviru
replic
notabl
half
maxim
cytotox
concentr
cc
oxysterol
shown
order
obtain
first
largescal
unbias
view
effect
two
oxysterol
cell
appli
quantit
proteom
approach
detect
variat
protein
express
upon
incub
model
cell
andor
particular
stabl
isotop
label
cell
cultur
silac
use
fulli
establish
reliabl
method
obtain
largescal
protein
quantif
hela
cell
line
exploit
model
system
larg
employ
vitro
antivir
studi
includ
relat
oxysterol
also
success
appli
sever
silacbas
studi
also
field
virolog
accord
silac
strategi
heavyand
lightlabel
cell
treat
vitro
vehicl
sterilefilt
ethanol
mix
heavi
light
cell
ratio
protein
extract
fraction
digest
analys
mass
spectrometri
identifi
rel
quantifi
accord
heavylight
silac
ratio
overal
protein
identifi
sampl
obtain
cell
tabl
rigor
qualiti
filter
appli
focu
analysi
high
qualiti
data
describ
materi
method
section
filter
total
number
protein
genuin
identifi
quantifi
hela
cell
respect
treat
overlap
replic
analys
remark
protein
identifi
quantifi
direct
revers
assay
protein
case
assay
qualiti
filter
appli
focu
genuin
identif
quantif
protein
modul
detect
appli
percentil
threshold
distribut
silac
ratio
obtain
sampl
notabl
sinc
main
task
report
proteom
analysi
investig
possibl
mechan
underli
antivir
effect
display
quit
similar
way
oxysterol
focus
protein
whose
cellular
express
either
increas
decreas
upon
treatment
sake
complet
whole
list
detail
protein
modul
oxysterol
provid
supplementari
tabl
tabl
report
protein
upregul
hela
cell
compar
control
cell
treat
vehicl
among
protein
upregul
oxysterol
nuclear
factorkappab
subunit
transcript
factor
play
role
inflamm
immun
function
might
actual
relat
viral
infect
also
antivir
properti
two
side
chain
oxysterol
precursor
protein
process
signaldepend
highli
induc
select
degrad
ctermin
portion
precursor
protein
work
altern
mechan
nfkb
activ
inde
sever
virus
shown
activ
nfkb
signal
usual
first
stage
infect
transient
way
nfkbdepend
induct
inflammatori
cytokin
synthesi
would
contribut
counteract
cell
invas
viral
particl
recogn
proinflammatori
properti
oxysterol
could
potenti
cytokin
product
provok
viru
actual
demonstr
cell
infect
herp
simplex
type
viru
howev
even
proteom
result
regard
well
fit
recent
avail
literatur
find
taken
care
due
high
cv
observ
tabl
list
tabl
protein
downregul
hela
cell
larg
major
protein
whose
cellular
content
result
significantli
reduc
hela
treatment
relat
lipid
synthesi
metabol
specif
sterol
synthesi
metabol
find
somehow
expect
still
proteom
analysi
oxysterol
treat
cell
provid
first
time
knowledg
meaning
preciou
data
instanc
investig
oxysterol
strongli
downregul
cellular
level
hydroxymethylglutarylcoa
hmgcoa
synthas
key
regulatori
enzym
cholesterol
synthet
pathway
consist
previou
literatur
show
hmgcoa
reductas
synthas
inhibitor
mean
mechan
convey
antivir
state
treat
cell
particularli
flavivirus
includ
hepatitit
c
viru
moreov
oxysterol
downregul
express
isopentenyldiphosph
deltaisomeras
crucial
regulatori
enzym
synthesi
isoprenoid
interestingli
excess
protein
isoprenyl
correl
cardiovascular
agerel
diseas
two
oxysterol
would
act
quencher
isoprenoid
synthesi
cellular
protein
found
downregul
three
like
implic
viral
entri
replic
name
interferoninduc
transmembran
protein
cation
independ
receptor
junction
adhes
molecul
jama
tabl
actual
appear
antivir
protein
induc
interferon
act
restrict
factor
inhibit
cell
entri
number
envelop
virus
influenza
viru
marburg
ebola
filovirus
sar
coronaviru
like
predominantli
local
endosom
level
like
interfer
endocytosismedi
viral
entri
progress
late
endosom
observ
case
african
swine
fever
viru
thu
find
would
exclud
fall
induc
mechan
underli
prove
antivir
activ
contrari
observ
reduct
downregul
mprci
jama
cellular
level
exert
appear
support
antivir
properti
display
side
chain
oxysterol
mprci
togeth
cation
depend
isoform
mprcd
one
special
transport
newli
synthes
lysosom
factor
includ
cathepsin
golgi
apparatu
late
endosom
le
recent
demonstr
rotaviru
strain
need
golgil
transport
mprci
cargo
cathepsin
effici
infect
cell
relat
prove
markedli
inhibit
rotaviru
replic
cell
line
report
diazsalina
colleagu
least
cathepsin
b
l
involv
golgil
traffic
modul
mprci
silac
experi
show
signific
downregul
cathepsin
hela
cell
treat
supplementari
materi
tabl
exclud
also
isoform
could
contribut
infect
least
defin
rotaviru
strain
importantli
mpr
appear
pivot
replic
sever
virus
vaccinia
viru
protein
local
le
interact
protein
associ
lederiv
transport
vesicl
biogenesi
mpr
facilit
assembl
extracellular
form
viru
hsv
glycoprotein
gd
essenti
viru
enter
cell
effici
bind
mprci
interact
play
role
viru
entri
egress
recent
studi
dohgu
colleagu
show
mpr
involv
replic
cycl
dissemin
human
immunodefici
viru
facilit
pass
blood
brain
barrier
must
outlin
fact
among
protein
whose
cellular
level
diminish
oxysterol
treatment
thu
mprci
independ
golgil
pathway
may
compens
specif
decreas
given
transport
howev
actual
coinvolv
oxysterolinduc
deficit
cell
mprci
protect
effect
rotaviru
infect
could
reinforc
evid
defin
rotaviru
strain
includ
human
one
util
tight
junction
protein
jama
coreceptor
enter
enterocyt
cell
solid
proof
actual
avail
indic
sever
viru
famili
exploit
variou
tight
junction
protein
enter
replic
even
exit
target
cell
jama
use
reoviru
rotaviru
facilit
infect
process
note
jama
mprci
differ
local
cell
first
bound
plasma
membran
second
cytoplasm
membran
henc
tight
junction
protein
appear
first
critic
target
virus
reach
le
second
step
enter
cytosol
vesicl
modul
jama
express
assess
immunoblot
analysi
treatment
hela
cell
line
significantli
p
anova
decreas
jama
protein
level
respect
fig
b
modul
compar
silac
ratio
obtain
proteom
analysi
correspond
direct
assay
revers
assay
result
confirm
immunoblot
cell
fig
quit
larg
portion
protein
result
either
upor
regul
one
oxysterol
enzymat
origin
consid
present
studi
involv
cholesterol
isoprenoid
metabol
evid
provid
like
modul
key
cell
metabol
pathway
andor
certainli
preliminari
need
deeper
investig
group
focus
sterol
metabol
still
data
report
provid
use
clue
focus
research
present
studi
carri
technic
advanc
proteom
screen
cell
model
system
hela
cell
line
commonli
employ
vitro
test
antivir
efficaci
wide
varieti
compound
cellular
treatment
perform
concentr
statist
signific
differ
assess
one
way
analysi
varianc
one
way
anova
p
anova
p
anova
p
anova
two
oxysterol
demonstr
significantli
inhibit
viral
replic
larg
number
viral
pathogen
without
induc
cytotox
focus
antivir
activ
two
oxysterol
identifi
two
new
mechan
inhibit
viru
entri
diffus
within
infect
cell
inde
shown
abl
downregul
junction
adhes
moleculea
cation
independ
isoform
receptor
two
crucial
molecul
number
virus
exert
infect
research
commun
first
report
cell
proteom
modul
two
side
chain
oxysterol
ie
certainli
primari
interest
human
pathophysiolog
two
oxysterol
shown
group
upregul
redox
sensit
transcript
factor
nfkb
viru
infect
cell
way
boost
cellular
proinflammatori
reaction
viru
addit
previous
report
surviv
signal
trigger
low
micromolar
concentr
human
promonocytyc
cell
line
depend
rapid
transient
activ
nadphoxidas
consequ
h
product
find
thu
indic
promis
way
deeper
elucid
actual
contribut
redox
reaction
antivir
effect
